Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Robert Jeanfreau

Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) in Adolescents and Adults: A Phase III Randomized Study

Human Vaccines and Immunotherapeutics

English

Related publications

Antibody Persistence Up to 5 Y After Vaccination With a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine in Adolescents

Human Vaccines and Immunotherapeutics

English

Safety and Immunogenicity of a Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine When Co-Administered With Influenza Vaccine in Adults

Human Vaccines

2009

English

Safety, Immunogenicity, and Immune Memory of a Novel Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (MCV-4) in Healthy Adolescents

Archives of Pediatrics & Adolescent Medicine

2005

English

SAFETY AND IMMUNOGENICITY OF GROUP B STREPTOCOCCAL (GBS) POLYSACCHARIDE (PS) TYPES Ia AND Ib-Tetanus TOXOID (Ia-Tt; Ib-Tt) CONJUGATE VACCINES IN WOMEN.▴ 980

English

Immunogenicity and Safety of 1 vs 2 Doses of Quadrivalent Meningococcal Conjugate Vaccine in Youth Infected With Human Immunodeficiency Virus

Journal of Pediatrics

English

Immunogenicity and Safety of a Combined DTPa-IPV/Hib Vaccine Administered as a Three-Dose Primary Vaccination Course in Healthy Korean Infants: Phase III, Randomized Study

Human Vaccines and Immunotherapeutics

English

Persistence of Bactericidal Antibodies Following Early Infant Vaccination With a Serogroup B Meningococcal Vaccine and Immunogenicity of a Preschool Booster Dose

CMAJ

Medicine

2013

English

Effects of Prior Polysaccharide Vaccination on Magnitude, Duration, and Quality of Immune Responses to and Safety Profile of a Meningococcal Serogroup C Tetanus Toxoid Conjugate Vaccination in Adults

Clinical Diagnostic Laboratory Immunology

2004

English

Safety and Immunogenicity of a mRNA-based Chikungunya Vaccine in a Phase 1 Dose-Ranging Trial

International Journal of Infectious Diseases

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Robert Jeanfreau

Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) in Adolescents and Adults: A Phase III Randomized Study

Related publications

Antibody Persistence Up to 5 Y After Vaccination With a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine in Adolescents

Safety and Immunogenicity of a Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine When Co-Administered With Influenza Vaccine in Adults

Safety, Immunogenicity, and Immune Memory of a Novel Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (MCV-4) in Healthy Adolescents

SAFETY AND IMMUNOGENICITY OF GROUP B STREPTOCOCCAL (GBS) POLYSACCHARIDE (PS) TYPES Ia AND Ib-Tetanus TOXOID (Ia-Tt; Ib-Tt) CONJUGATE VACCINES IN WOMEN.▴ 980

Immunogenicity and Safety of 1 vs 2 Doses of Quadrivalent Meningococcal Conjugate Vaccine in Youth Infected With Human Immunodeficiency Virus

Immunogenicity and Safety of a Combined DTPa-IPV/Hib Vaccine Administered as a Three-Dose Primary Vaccination Course in Healthy Korean Infants: Phase III, Randomized Study

Persistence of Bactericidal Antibodies Following Early Infant Vaccination With a Serogroup B Meningococcal Vaccine and Immunogenicity of a Preschool Booster Dose

Effects of Prior Polysaccharide Vaccination on Magnitude, Duration, and Quality of Immune Responses to and Safety Profile of a Meningococcal Serogroup C Tetanus Toxoid Conjugate Vaccination in Adults

Safety and Immunogenicity of a mRNA-based Chikungunya Vaccine in a Phase 1 Dose-Ranging Trial